Fragen? Antworten! Siehe auch: Alternativlos
Practice Fusion agreed to pay $145 million to resolve civil and criminal cases, according to documents filed in a Vermont federal court. Practice Fusion admitted to the scheme with an unnamed opioid maker, though the details of the government case closely match a public research partnership between Practice Fusion and Purdue Pharma Inc., which makes OxyContin.
Mit anderen Worten: Da wird es mehr als einen zahlenden Drogenpusherkonzern gegeben haben.